Skip to main content

Work Begins on Massive TMC3 Project

Published Aug 31, 2021 by A.J. Mistretta

TMC3 Aerial July 2022

Aerial rendering of TMC3

Work has begun on TMC3, the much-anticipated life sciences research and commercialization campus that backers believe will become a robust global nexus for that work in the years to come. 

The Texas Medical Center announced on August 31 that construction has begun on phase one of the 37-acre project, which is backed by $1.8 billion in secured financing. The full TMC3 master plan, set to materialize over several years, spans more than 6 million square feet of development. Officials say TMC3 will result in 42,000 new jobs and an annual economic impact of $5.4 billion. 

Phase one will include 950,000 square feet dedicated to translational research anchored by Boston-based Beacon Capital Partners and its strategic partner Braidwell, a life sciences-focused investment firm. The first phase will also include a 500+ room hotel with more than 650,000 square feet of conference space, a 350-unit residential tower, parking and nearly 19 acres of public space including parks. 

“With more than 100,000 employees, vast intellectual capital and a long-standing patient focus, our capacity for innovation is second to none,” said William McKeon, President & CEO of TMC. “The collective power of TMC’s hospitals and academic institutions has accelerated the pace of scientific discovery for years. TMC3 extends our collaboration to Fortune 100 life sciences companies and entrepreneurial ventures. The impact on patients worldwide has the potential to be nothing short of life-changing.”

TMC3 was designed by Boston-based Elkus Mafredi Architects, which has designed several of Massachusetts’ major life sciences complexes. According to a release from TMC: “The plan emphasizes creative collisions between people, institutions, and ideas, bolstered by a state-of-the-art infrastructure that will support a mix of healthcare, life science and business users. In addition, purposeful, growth focused capital investments will foster an ever-expanding network of business partners, from entrepreneurial ventures to Fortune 100 companies.”

TMC3's founding institutions — the TMC, Baylor College of Medicine, Texas  A&M University Health Science Center, the University of Texas Health Science Center at Houston and the University of Texas M.D. Anderson Cancer Center — will each have their own dedicated facilities on the campus when its complete.
 

Learn more about TMC3 and life sciences in Houston. 

Related News

Economic Development

Houston's Life Sciences Sector on the Verge of a New Era

2/27/24
Houston continues to evolve as a premier destination for life sciences and biomanufacturing through a multifaceted strategy that capitalizes on its existing strengths and fosters innovation and growth.   Since its inception in 1945, the Texas Medical Center has evolved into a vast medical district spanning 5 square miles  and serving over ten million patients annually.  More than 60 institutions operate within the Texas Medical Center, serving as a catalyst for Houston’s collaborative ecosystem, with efforts like the Cell Therapy Manufacturing Center, JLABS@TMC and CUBIO. This helps set the stage for groundbreaking research and provides direct access to nearly 5,000 active clinical trials, a major boon to innovation.   Recent years have witnessed significant strides in laying a robust foundation for Houston's position as a leader in innovative life sciences and biotechnology. These efforts came into focus last month at Bisnow’s Life Sciences Evolution event, with leaders in the life sciences industry, real estate and innovation envisioning the future growth of the Houston life sciences market. Among the assets shared as advantages were access to clinical trials, business environment, workforce efforts and quality of life.   “Having access to the patient population is critical to success, especially a diverse population,” Monique Knighten, PhD of Portal Innovations said. “There’s a key benefit to have access to these clinical trials and the expertise involved, as well as living close to where the science is being developed.”   Legislative actions, such as the passage of Proposition 10 in November which provides new incentives for medical device and pharmaceutical manufacturing companies, enhances the region's competitiveness and economic prospects. Additionally, investments in workforce development, exemplified by collaborations between educational institutions and industry partners like San Jacinto College and the National Institute for Bioprocessing Research and Training (NIBRT), ensure a skilled talent pool for the future.  “The relationships with companies, colleges and high schools are integral,” Pearland EDC Vice President Brian Malone said on the panel at Bisnow discussing suburban life sciences growth. “We’ve really worked hard on that with a business retention plan to find out what type of training and what type of workers these companies need.”   Furthermore, substantial real estate investments further support life sciences research and development. TMC’s Helix Park opened in 2023 with the TMC Collaborative Building and industry research hub Dynamic One, with new tenant Houston Methodist leasing 75,800 square feet. Just north inside the Medical District, Hines’ Levit Green is now leasing nearly 300,000 square feet of purpose-built lab and office space as part of a future 53-acre district. On the northeast side of the metro, McCord’s master-planned Generation Park recently broke ground on a new Center for Biotechnology in partnership with San Jacinto College. In The Woodlands, Alexandria is developing 8800 Technology Forest Place into 325,000 square feet of Class A space.   Initiatives such as the Cancer Prevention Research Institute of Texas (CPRIT) and a thriving innovation ecosystem further reinforce the city's position at the forefront of bioscience breakthroughs and economic impact.  With strategic advantages like its top-ranked port, diverse population, and accessibility to global markets, Houston is poised to further elevate its status as a hub for life sciences innovation. As Houston continues to advance its life sciences and biotechnology sector, opportunities for collaboration and growth abound, driving progress in public health and driving the next wave of bioscience innovation.   Explore Houston's dynamic life sciences ecosystem.  
Read More
Economic Development

Houston Primed for Life Sciences Boom

5/17/23
The life sciences industry is a global force driving medical innovation and advancements in health care. From pharmaceuticals and biotechnology to medical devices and diagnostics, this sector plays a crucial role in improving the quality of life for people around the world. As the industry continues to grow and evolve, new hubs of innovation are emerging, each with its unique strengths and advantages.  Houston is a world-class region with a thriving innovation economy. With a high concentration of employment, healthy funding scene, and unwavering commitment to translational research, the Houston region has positioned itself as one of the country's fastest-growing life sciences ecosystems - ranking #13 in a 2022 CBRE industry study. Bright scientific minds, entrepreneurial drive and an active investment community gives companies fertile ground for disruptive innovation in biotech and life sciences.  The Texas Medical Center (TMC), the world's largest medical district, offers companies a unique opportunity to collaborate and implement technology in one of the largest healthcare ecosystems. TMC and the variety of research institutions and innovative companies who operate in Houston are taking on the greatest medical challenges of our generation.  Houston is home to over 1,700 life sciences and health care companies and establishments, making it a top-15 market for life sciences employment nationwide and first in Texas. This robust and diverse workforce, coupled with an extensive education infrastructure and world-class research institutions, makes Houston a prime location to support growth across key subsectors like cell and gene therapy manufacturing, molecular diagnostics, and biologics drug development and manufacturing.  In addition to established companies, Houston has a vibrant startup ecosystem that provides support and resources for early-stage companies. The city has several startup incubators and accelerators, including TMCx, which is located within the Texas Medical Center and provides startups with access to mentors, funding, and other resources. TMCx has hosted over 300 companies with over $5.8 billion raised. Additionally, Houston has a strong network of angel investors and venture capitalists that are actively seeking out innovative life sciences companies to invest in.  With the densest patient population in the world, Houston allows for transformational clinical applications. The region ranks second in the nation in clinical trial volume, with 4,906 active clinical trials in 2022, representing over 20 percent of all active U.S. trials. Companies located in Houston can also leverage unique funding programs. In 2022, National Institutes of Health (NIH) awarded 1,752 grants totaling $961 million represented for Houston. The Cancer Prevention and Research Institute of Texas (CPRIT) has also committed $6 billion in funding for groundbreaking cancer research, prevention and product development programs for companies located in Texas. Since its inception in 2009, CPRIT has awarded more than $3 billion in grants for cancer research, of which MD Anderson has received approximately 20 percent.  Houston also has a growing number of life sciences developments that encourage innovation and collaboration between industry partners. Generation Park, a 4,200-acre master-planned development, is creating a thriving ecosystem for companies to grow and provides a place where education and industry can converge. It will be the home of the San Jacinto Biotechnology Center, a biomanufacturing workforce institute that will offer certificate coursework in bioprocessing to students as part of a strategic partnership with the National Institute for Bioprocessing Research and Training (NIBRT). TMC Helix Park is another life sciences development that will provide 6 million square feet of research labs, retail, hotel, and large scale commercialization space, in addition to TMC3, a collaborative research building with four founding institutions. According to the Real Deal, the University of Texas MD Anderson Cancer Center plans to build a $668 million laboratory expansion that will connect to TMC Helix Park. Construction is expected to begin in September, with completion estimated in late 2027. Levit Green is a 53-acre mixed-use life sciences district under construction near Texas Medical Center that is expected to be completed this year. The initial five-story building will create 294,000 square feet of space overlooking a plaza and a man-made lake. Texas A&M Innovation Plaza located in the Texas Medical Center is expected to be completed in 2024. Consisting of research facilities, affordable student housing, office space, retail space and parking, the Innovation Plaza will be home to the Texas A&M Engineering Medicine (EnMed) program and provide student housing for the Prairie View A&M University’s College of Nursing. This project is part of Houston's ongoing investment in programs that will grow the talent pipeline and prepare its future workforce. The Partnership’s economic development team will be attending BIO International in Boston from June 5-8th to spotlight the region’s thriving life sciences ecosystem and its unique opportunities for innovation and growth.
Read More

Related Events

Economic Development

Houston's Advancements in Biotechnology

Join us for an insightful panel on the life science and biotechnology industry, where experts will dive into the latest trends, innovations, and transformative developments shaping the field. Our panelists, each…

Learn More
Learn More
Executive Partners